Imunon Inc investor relations material
Listen to the latest call from Imunon Inc
Imunon Inc., formerly Celsion Corporation, a clinical stage biotechnology company, focuses on the development of novel theragnostic technologies for cancer, including the use of radiolabeled DNA plasmids to treat cancer. Celsion has developed, among other, ThermoDox, a DNA plasmid with its proprietary heat-activated liposomal delivery technology, which is designed to improve the effectiveness of cancer immunotherapies such as vaccines and adoptive cell therapies. The company's customers are pharmaceutical and biotechnology companies, research institutions, hospitals and clinics.
Ticker
IMNNCountry
USAbout
IR-page